Three FDA advisory panel members resign over approval of Alzheimer’s drug
Improving bone marrow transplants in mice to help fight disease
11 June 2021Study finds brain areas involved in seeking information about bad possibilities
11 June 2021Three FDA advisory panel members resign over approval of Alzheimer’s drug
Three members of a US Food and Drug Administration (FDA) advisory committee, which advised against authorising the Alzheimer’s disease drug aducanumab because of a lack of efficacy, have resigned…
